The CFS, serum haemoglobin concentration and serum albumin concentration in our study were associated with the need for Em-TAVR and 1-year mortality after Em-TAVR. The gene discussed is ALB; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.